News
A challenging economic environment is constricting biotech deal flow. But for well-capitalized Lantheus, these tough times present an opportunity to build out its R&D pipeline. Buoyed by a new ...
COIMBATORE: Two men were arrested in Coimbatore district on Saturday for sale of mephentermine sulphate vials without licence. The Mettupalayam police seized 2,275 vials worth ₹10 lakh ...
Lantheus has filed what it says is the first generic version of Novartis’ big-selling cancer radionuclide therapy Lutathera in the US, used to treat rare neuroendocrine tumours (NETs).
Short interest in Lantheus Holdings Inc (NASDAQ:LNTH) decreased during the last reporting period, falling from 6.46M to 6.42M. This put 12.34% of the company's publicly available shares short.
Eli Lilly's drive to provide as many treatment options as possible for its weight-loss drug Zepbound has continued with the launch of new high-dose vials sold at a $150 discount to its auto ...
The strategy’s top position, healthcare firm Lantheus Holdings LNTH, returned more than 60% as it reported both earnings and revenue well above Wall Street’s expectations. Strong stock ...
Carillon Chartwell Small Cap Fund earns a High Process Pillar rating. The largest contributor to the rating is its parent firm's impressive long-term risk-adjusted performance, as shown by the ...
The differences between PFSs and MDVs (per 1000 doses) is 324.21. MDV: Multidose vial; NA: Not available; PFS: Prefilled syringe. Prefilled syringes (PFSs) have gained market share in the USA ...
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results